News
Moderna, FDA and Covid
Digest more
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results